Insulin, Long-ActingInsulinsInsulin AspartHypoglycemic AgentsInsulinHemoglobin A, GlycosylatedClinical Trials, Phase III as TopicDiabetes Mellitus, Type 2Drug Administration ScheduleInsulin, IsophaneBlood GlucoseReceptor, InsulinInsulin Infusion SystemsBiphasic InsulinsTreatment OutcomeDiabetes Mellitus, Type 1Insulin LisproHypoglycemiaInfusions, SubcutaneousGlucoseInsulin ResistanceIslets of LangerhansGlucagonInsulin, Regular, PorkGlucose Clamp TechniqueHyperglycemiaInsulin, Regular, HumanC-PeptideGlucose Tolerance TestPostprandial PeriodSulfonylurea CompoundsInsulin-Secreting CellsInsulin Receptor Substrate ProteinsFatty Acids, NonesterifiedMetforminPharmaceutic AidsInfusion Pumps, ImplantableSomatostatinFastingChronotherapyHyperinsulinismInsulin AntibodiesVenomsGlucagon-Like Peptide 1Blood Glucose Self-MonitoringInsulin Antagonists3-Hydroxybutyric AcidPerioperative PeriodInjections, SubcutaneousDiabetes MellitusDose-Response Relationship, DrugBody WeightDrug Therapy, CombinationLiverPancreasAdipose TissueWeight GainTime FactorsObesityRats, WistarProinsulinCross-Over StudiesInfusions, IntravenousDogsCells, CulturedEpinephrineMuscle, SkeletalSignal Transduction